Novel MRI Techniques on Evaluation of Lymphedema

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20+
SponsorNational Taiwan University Hospital

About this trial

In this project, the investigators aim to investigate the imaging approaches for breast cancer-related secondary lymphedema. The clinical study aims to optimize the conventional MRI methods for mapping lymphedema and assess the post-surgical therapeutic effects in longitudinal follow-up studies. Additionally, a normal imaging database of lymphedema MRI images will be established for future reference. For pre-clinical animal study, investigators aim to develop and integrate two novel MRI methods, including free water elimination diffusion MRI and diffusion kurtosis MRI techniques. By integrating clinical and pre-clinical studies, the investigators aim to establish a precise imaging tool for evaluating the therapeutic effects of lymphedema for following translational applications.

Eligibility criteria

Qualifiers

adults with breast cancer related lymphedema

Disqualifiers

children younger than 20 years old

pregnancy

The cardiac implantable electronic device (CIED) such as pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices.

Metallic intraocular foreign bodies.

Trial design

Treatments tested in this trial

  • Diffusion magnetic resonance imaging

Treatment groups

210 Participants
are divided into 1 treatment group

Locations

1
National Taiwan university hospital Taipei Taiwan

Sponsors and collaborators

National Taiwan University Hospital

Lead sponsor

National Health Research Institutes, Taiwan

Collaborator